Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: a single-center cohort study. Fernandez-Ruiz M, Lopez-Medrano F, Asin MAP, de la Calle GM, et al. J Med Virol 2020 Jul 16. doi: 10.1002/jmv.26308.

Read + Share

Amedeo Smart

Independent Medical Education

Fernandez-Ruiz M, Lopez-Medrano F, Asin MAP, de la Calle GM, et al. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: a single-center cohort study. J Med Virol 2020 Jul 16. doi: 10.1002/jmv.26308.
PMID: 32672860